Filing Details

Accession Number:
0001209191-24-004385
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-05 16:58:53
Reporting Period:
2024-03-01
Accepted Time:
2024-03-05 16:58:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1557746 Aclaris Therapeutics Inc. ACRS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1304113 William Kenneth Andrew Powell C/O Aclaris Therapeutics, Inc.
701 Lee Road, Suite 103
Wayne PA 19087
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-03-01 8,500 $1.23 22,863 No 4 P Direct
Common Stock Acquisiton 2024-03-04 6,000 $1.25 28,863 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $1.230 to $1.2393, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $1.230 to $1.269, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.